| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to the chemical-pharmaceutical industry, and represents using a biologically active agent for preparing a drug for metabolic disorders specified in a group consisting of insulin resistance syndrome and diabetes mellitus, including type I diabetes mellitus and type II diabetes mellitus, and obesity, wherein the agent represents a compound of formula,wherein n=1 or 2; m=0, 1, 2, 4 or 5; q=0; t=0 or 1; Rrepresents hydrogen; A is phenyl, unsubstituted or substituted by 1 or 2 alkyls having 1 or 2 carbon atoms; and Ris hydrogen or alkyl having 1 or 2 carbon atoms; or when Rrepresents hydrogen - a pharmaceutically acceptable salt of the compound.EFFECT: preparing the drug for metabolic disorders.18 cl, 6 ex, 22 tbl |
